Amgen Inc.

NAS : AMGN
Pharmaceuticals
Thousand Oaks California
2011 Revenue (US$ Millions)$15,582
2010 Revenue (US$ Millions)$15,053
Revenue Growth (%)3.51%
Net Income (US$ Millions)$3,683
Common Shares Outstanding (Millions)$796
Earnings Per Share (US$)$4.04
Earnings Per Share Growth (%)-15.66%
Price To Earnings Ratio15.91
Total Equity (US$ Millions)$19,029
Profit Growth (%)-20.4
Profit Margin (%)23.64%
Return On Equity (%)15.38%
Long Term Debt (US$ Millions)$21,344
Debt To Equity Ratio (%)1.12%
Market Capitalization (US$ Millions)$51,085
Total Assets (US$ Millions)$48,871
Return on Assets (%)8.47
Current Assets (US$ Millions)$27,593
Inventories (US$ Millions)$2,484
Current Liabilities (US$ Millions)$5,754
Cost of Goods Sold (US$ Millions)$2,427
Asset Turnover0.32
Inventory Turnover1.08